2021
Defibrillation Safety Margin Testing in Patients With Congenital Heart Disease Results From the NCDR
Prutkin JM, Wang Y, Escudero CA, Stephenson EA, Minges KE, Curtis JP, Hsu JC. Defibrillation Safety Margin Testing in Patients With Congenital Heart Disease Results From the NCDR. JACC Clinical Electrophysiology 2021, 7: 1145-1154. PMID: 33933411, DOI: 10.1016/j.jacep.2021.02.019.Peer-Reviewed Original ResearchConceptsCongenital heart diseaseLowest successful energyHospital stayNational Cardiovascular Data Registry ICD RegistryImplantable cardioverter-defibrillator insertionVentricular septal defectTetralogy of FallotHeart disease resultHospital complicationsHospital deathHospital outcomesMultivariable adjustmentEbstein's anomalyICD RegistryICD recipientsSeptal defectCommon ventricleHeart diseaseRetrospective analysisLower oddsGreat vesselsICD proceduresDisease resultsSuccessful energyICD generator
2017
Outcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly
Taggart NW, Cabalka AK, Eicken A, Aboulhosn JA, Thomson JDR, Whisenant B, Bocks ML, Schubert S, Jones TK, Asnes JD, Fagan TE, Meadows J, Hoyer M, Martin MH, Ing FF, Turner DR, Latib A, Tzifa A, Windecker S, Goldstein BH, Delaney JW, Kuo JA, Foerster S, Gillespie M, Butera G, Shahanavaz S, Horlick E, Boudjemline Y, Dvir D, McElhinney DB, Registry V. Outcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly. The American Journal Of Cardiology 2017, 121: 262-268. PMID: 29153244, DOI: 10.1016/j.amjcard.2017.10.017.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedBioprosthesisCardiac CatheterizationEbstein AnomalyEndocarditisFemaleHeart Valve ProsthesisHeart Valve Prosthesis ImplantationHumansMaleMiddle AgedPostoperative ComplicationsProsthesis FailureRegistriesReoperationThrombosisTreatment OutcomeTricuspid ValveTricuspid Valve InsufficiencyYoung AdultConceptsEbstein's anomalyValve dysfunctionValve implantationTricuspid valveAcute valve thrombosisMedium-term durabilityPatient underwent reinterventionPatient-prosthesis mismatchSevere tricuspid regurgitationTranscatheter Tricuspid ValveNYHA statusProcedural mortalityTranscatheter tricuspidUnderwent reinterventionMelody valveValve thrombosisMost patientsTricuspid regurgitationCommon indicationAcute resultsSurgical bioprosthesesInternational registryInvasive alternativePatientsTVIVComplications Associated With Implantable Cardioverter Defibrillators in Adults With Congenital Heart Disease or Left Ventricular Noncompaction Cardiomyopathy (From the NCDR® Implantable Cardioverter-Defibrillator Registry)
Gleva MJ, Wang Y, Curtis JP, Berul CI, Huddleston CB, Poole JE. Complications Associated With Implantable Cardioverter Defibrillators in Adults With Congenital Heart Disease or Left Ventricular Noncompaction Cardiomyopathy (From the NCDR® Implantable Cardioverter-Defibrillator Registry). The American Journal Of Cardiology 2017, 120: 1891-1898. PMID: 28917495, DOI: 10.1016/j.amjcard.2017.07.103.Peer-Reviewed Original ResearchConceptsCongenital heart diseaseComplication rateVentricular noncompaction cardiomyopathyHeart diseaseHospital complicationsEbstein's anomalyCardiac resynchronizationSeptal defectNoncompaction cardiomyopathyImplantable cardioverter defibrillator implantationDual chamberAcute lead dislodgmentsSingle-chamber ICDCardioverter-defibrillator implantationPeriprocedural complication rateGreater complication rateVentricular septal defectTetralogy of FallotAtrial septal defectImplantable cardioverter defibrillatorChildhood heart diseaseSingle-chamber devicesChi-square testHospital deathAdult patients
2014
Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus—A case report
Danve A, Perry L, Deodhar A. Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus—A case report. Seminars In Arthritis And Rheumatism 2014, 44: 195-197. PMID: 25005336, DOI: 10.1016/j.semarthrit.2014.05.006.Peer-Reviewed Original ResearchConceptsActive systemic lupus erythematosusSystemic lupus erythematosusUse of belimumabCase reportLupus erythematosusPresence of SLEMild Ebstein's anomalyFirst case reportBelimumab usePregnancy RegistryActive lupusUnacceptable toxicityEbstein's anomalyUneventful coursePoor outcomeCaucasian womenBelimumabPregnancyModerate dosesMycophenolateErythematosusReportRelevant literatureAzathioprinePrednisone
1994
Radiofrequency Ablation of an Accessory Pathway in a Patient with Corrected Ebstein's Anomaly
KOCHERIL A, ROSENFELD L. Radiofrequency Ablation of an Accessory Pathway in a Patient with Corrected Ebstein's Anomaly. Pacing And Clinical Electrophysiology 1994, 17: 986-990. PMID: 7517536, DOI: 10.1111/j.1540-8159.1994.tb01444.x.Peer-Reviewed Original Research
1991
Tricuspid valve disease with significant tricuspid insufficiency in the fetus: Diagnosis and outcome
Hornberger L, Sahn D, Kleinman C, Copel J, Reed K. Tricuspid valve disease with significant tricuspid insufficiency in the fetus: Diagnosis and outcome. Journal Of The American College Of Cardiology 1991, 17: 167-173. PMID: 1987222, DOI: 10.1016/0735-1097(91)90722-l.Peer-Reviewed Original ResearchConceptsTricuspid valve diseasePulmonary atresiaPulmonary stenosisEbstein's anomalyClinical courseValve diseaseUnguarded tricuspid valve orificeSevere congestive heart failureAssociated cardiac lesionsBenign neonatal courseComplex heart lesionsPulmonary outflow obstructionRight atrial dilationRight-sided cardiomegalySignificant tricuspid insufficiencySignificant tricuspid regurgitationCongestive heart failurePulmonary artery flowTricuspid valve dysplasiaTricuspid valve orificeTricuspid tissueNeonatal courseOutflow obstructionTricuspid insufficiencyTricuspid regurgitation
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply